Benzoyl peroxide

CAS No. 94-36-0

Benzoyl peroxide( —— )

Catalog No. M19506 CAS No. 94-36-0

A peroxide derivative that has been used topically for BURNS and as a dermatologic agent in the treatment of ACNE and POISON IVY DERMATITIS.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Benzoyl peroxide
  • Note
    Research use only, not for human use.
  • Brief Description
    A peroxide derivative that has been used topically for BURNS and as a dermatologic agent in the treatment of ACNE and POISON IVY DERMATITIS.
  • Description
    A peroxide derivative that has been used topically for BURNS and as a dermatologic agent in the treatment of ACNE and POISON IVY DERMATITIS. It is used also as a bleach in the food industry.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    ROS
  • Recptor
    ROS activator
  • Research Area
    ——
  • Indication
    Rosacea

Chemical Information

  • CAS Number
    94-36-0
  • Formula Weight
    242.23
  • Molecular Formula
    C14H10O4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:>10 mM
  • SMILES
    O=C(OOC(=O)C1=CC=CC=C1)C1=CC=CC=C1
  • Chemical Name
    benzoic peroxyanhydride

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Bojar RA et al. Br J Dermatol. 1995 Feb;132(2):204-8.
molnova catalog
related products
  • Daidzin 6''-O-malona...

    Daidzin 6''-O-malonate may have anticancer activity.

  • Moracin C

    Moracin C, a natural compound found in Morus mesozygia, Morus alba var. multicaulis, is an anti-inflammatory agent.

  • DS-6051b

    DS-6051b is a new-generation selective inhibitor of ROS1/NTRK including ROS1,NTRK1,NTRK2 and NTRK3 with IC50 of 0.207 nM,0.622 nM,2.28 nM and 0.980 nM, respectively.DS-6051b inhibited the growth of the ROS1 fusion-positive HCC78 cancer cell line and the CD74-ROS1 overexpressed Ba/F3 cells.